Loading quotes...
Forecast
| Buy |
5 |
| Hold |
3 |
| Sell |
0 |
News Go to news feed
Danaher posts stronger margin and more optimistic outlook, pushing European stocks higher
Danaher surprised in the first quarter with an adjusted operating margin of 30.2 percent, topping the consensus estimate of 28.3 percent. For the second quarter the company issued a slightly more optimistic adjusted earnings-per-share outlook. The figures supported prices in Europe: Merck rose 2.1 percent, Sartorius 4.4 percent, and Danaher was also trading higher in premarket trading. » More on finanzen.net
Danaher announces 3–6% revenue target for 2026 and emphasizes bioprocess growth
Danaher expects 3–6% revenue growth in 2026, driven mainly by the bioprocess business, and is aiming for high-single-digit earnings growth even at the low end of the range. The acquisition of Masimo is expected to improve margins and growth and deliver a high-single-digit return on invested capital by year five. Reshoring initiatives will require multi-year CapEx investments, while China-related factors could dent revenue by $75–100 million. The company remains open to further acquisitions and views AI and a recovery in the life-science sector as long-term growth drivers. » More on de.investing.com
Danaher to buy Masimo for $9.9 billion in $180-per-share all-cash deal
Danaher agreed to acquire Masimo for $180 per share in an all-cash transaction valuing the deal at about $9.9 billion, implying roughly 18x estimated 2027 EBITDA (about 15x including expected synergies). Masimo will operate as a standalone business within Danaher’s Diagnostics segment, and Danaher expects more than $125 million in annual cost synergies and $50 million in annual revenue synergies by the fifth year. The acquisition is projected to be modestly accretive, adding $0.15–$0.20 to adjusted diluted EPS in the first full year and about $0.70 by year five, and is expected to close in H2 2026. » More on finance.yahoo.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 5.75B | 11.24% |
| Gross profit | 3.37B | 11.89% |
| Net profit | 1.08B | 39.74% |
| EBITDA | 1.11B | 26.25% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €815.81B |
Number of shares | 726.86M |
52-week high/low | €1,354.28 - €1,067.86 |
| Dividends | No |
Beta | 0.80 |
P/E ratio | 37.26 |
PEG ratio | 1.47 |
P/B ratio | 2.99 |
P/S ratio | 6.26 |
Company profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
| Name | DANAHER CORP. PFD.SER.B |
| CEO | Rainer M. Blair |
| Headquarters | Washington,
dc USA |
| Website | |
| Sector | Industrials |
| Industry | Electrical Equipment |
| IPO | 05/11/2020 |
| Employees | 79,000 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | DHR-PB |